Trial intelligence / Profile preview

Genicular Nerve Block for Knee Osteoarthritis

NCT07174167Completed

Sponsor
Haydarpaşa Numune Training and Research Hospital
Start
Apr 2023
Primary completion
Feb 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of prilocaine and triamcinolone in knee osteoarthritis (OA) (3 arms), sponsored by Haydarpaşa Numune Training and Research Hospital. Primary endpoint: Pain Intensity at 1 month. Started Apr 2023; status: completed.

02

Drugs

prilocainetriamcinolone
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07174167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07174167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call